Catherine Sylvain

This inventor holds 65 USPTO granted patents and 5 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Pyrimidine Compounds (CPC class C07D). Top assignees: Rigel Pharmaceuticals, Incorporated, Onyx Therapeutics, Inc., Rogel Pharmaceuticals, Inc.. Active years: 2006-2022.

USPTO Granted Patents = 65 (Patent Applications = 5)

% Patents Active = 63.1

CIPO Patents = 5

EPO Patents = 8 (Patent Applications = 4)

Average Co-Inventor Count = 8.8

ph-index = 31

Forward Citations = 2,867(Granted Patents)

Forward Citations (Not Self Cited) = 2,464(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Burligame, CA (US) (2006)
Burlingame, CA (US) (2006 - 2015)
San Mateo, CA (US) (2008 - 2022)

Company Filing History:

55 out of 492

Rigel Pharmaceuticals, Incorporated

patents

9 out of 50

Onyx Therapeutics, Inc.

patents

1 out of 1

Rogel Pharmaceuticals, Inc.

patent

Years Active: 2006-2022

Loading Chart...

Areas of Expertise:

Pyrimidine Compounds

Autoimmune Diseases

Enzyme Inhibition

Axl Inhibitors

Triazole Derivatives

2,4-Pyrimidinediamine

Compounds

Therapeutics

Chemical Uses

Pharmaceuticals

Drug Development

Biochemical Applications

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11230554 - Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds (2022-01-25),

2. 11007193 - 2,4-pyrimidinediamine compounds and their uses (2021-05-18),

3. 10828301 - 2,4-pyrimidinediamine compounds and their uses (2020-11-10),

4. 10709703 - 2,4-pyrimidinediamine compounds and their uses (2020-07-14),

5. 10682350 - 2,4-pyrimidinediamine compounds and their uses (2020-06-16),

6. 10369148 - 2,4-pyrimidinediamine compounds and their uses (2019-08-06),

7. 10314840 - 2,4-pyrimidinediamine compounds and their uses (2019-06-11),

8. 10259826 - Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds (2019-04-16),

9. 10166216 - Substituted triazoles useful as Axl inhibitors (2019-01-01),

10. 9913842 - 2,4-pyrimidinediamine compounds and their uses (2018-03-13),

11. 9751893 - Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds (2017-09-05),

12. 9657058 - Compounds for enzyme inhibition (2017-05-23),

13. 9586908 - 2,4-pyrimidinediamine compounds and their uses (2017-03-07),

14. 9540334 - 2,4-pyrimidinediamine compounds and their uses (2017-01-10),

15. 9499493 - 2,4-pyrimidinediamine compounds and their uses (2016-11-22),

Title: The Innovative Journey of Catherine Sylvain

Introduction: Catherine Sylvain, a pioneering inventor based in San Mateo, CA, has made significant contributions to the world of technology through her groundbreaking inventions and patents.

Latest Patents: Catherine Sylvain's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance security measures and a wearable health tracker that monitors vital signs in real-time.

Career Highlights: With a background in electrical engineering, Catherine Sylvain has a successful career marked by numerous accolades and awards for her innovative solutions in the fields of IoT, healthcare technology, and renewable energy.

Collaborations: Throughout her career, Catherine Sylvain has collaborated with leading tech companies, research institutions, and universities to further develop and commercialize her inventions. Her partnerships have led to the successful implementation of cutting-edge technologies in various industries.

Conclusion: Catherine Sylvain's passion for innovation and dedication to creating impactful solutions have solidified her reputation as a trailblazing inventor in the tech industry. Her relentless pursuit of excellence continues to inspire future generations of inventors and entrepreneurs.